Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares

被引:96
作者
Flayhart, D
Hindler, JF
Bruckner, DA
Hall, G
Shrestha, RK
Vogel, SA
Richter, SS
Howard, W
Walther, R
Carroll, KC
机构
[1] Johns Hopkins Med Inst, Div Med Microbiol, Dept Pathol, Baltimore, MD 21205 USA
[2] Univ Calif Los Angeles, Microbiol Lab, Med Ctr, Los Angeles, CA USA
[3] Cleveland Clin Fdn, Microbiol Lab, Cleveland, OH 44195 USA
[4] Univ Iowa Hlth Care, Dept Pathol, Iowa City, IA USA
关键词
D O I
10.1128/JCM.43.11.5536-5540.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) is among the strategies recommended by the Society for Healthcare Epidemiology of America for control of nosocomial MRSA infections. Infection control and laboratory personnel desire rapid, sensitive, and inexpensive methods to enhance surveillance activities. A multicenter study was performed to evaluate a new selective and differential chromogenic medium, BBL CHROMagar MRSA (C-MRSA) medium (BD Diagnostics, Sparks, MD), which enables recovery and concomitant identification of MRSA strains directly from nasal swab specimens taken from the anterior nares. Specimens were inoculated to C-MRSA and Trypticase soy agar with 5% sheep blood agar (TSA II, BD Diagnostics). Mauve colonies on C-MRSA at 24 h and 48 h and suspicious colonies on TSA II were confirmed as Staphylococcus aureus by Gram stain morphology and a coagulase test. In addition, the results of C-MRSA were compared to results of susceptibility testing (five different methods) of S. aureus strains isolated on TSA II. A total of 2,015 specimens were inoculated to C-MRSA and TSA II. Three hundred fifty-four S. aureus isolates were recovered; 208 (59%) were oxacillin (methicillin) susceptible and 146 (41%) were oxacillin resistant (MRSA). On C-MRSA, 139/146 or 95.2% of MRSA isolates were recovered, whereas recovery on TSA II was 86.9% (127/146) (P = 0.0027). The overall specificity of C-MRSA was 99.7%. When C-MRSA was compared to each susceptibility testing method, the sensitivity and specificity, respectively, were as follows: oxacillin MIC by broth microdilution, 94.4% and 96.7%; oxacillin screen agar, 94.3% and 96.7%; PBP2' latex agglutination, 93.7% and 98.5%; cefoxitin disk diffusion, 95.0% and 98.1%; and mecA PCR, 95.1% and 98.1%. In this study, C-MRSA was superior to TSA II for recovery of MRSA from surveillance specimens obtained from the anterior nares and was comparable to conventional, rapid, and molecular susceptibility methods for the identification of MRSA isolates.
引用
收藏
页码:5536 / 5540
页数:5
相关论文
共 18 条
[1]   Nosocomial methicillin-resistant and methicillin-susceptible, Staphylococcus aureus primary bacteremia:: At what costs [J].
Abramson, MA ;
Sexton, DJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :408-411
[2]   Oxacillin resistance screening agar base for detection of methicillin-resistant Staphylococcus aureus [J].
Becker, A ;
Forster, DH ;
Kniehl, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4400-4401
[3]   Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus [J].
Blot, SI ;
Vandewoude, KH ;
Hoste, EA ;
Colardyn, FA .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2229-2235
[4]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[5]  
*CLIN LAB STAT I, 2005, M100S15 CLIN LAB STA
[6]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[7]   Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection [J].
Davis, KA ;
Stewart, JJ ;
Crouch, HK ;
Florez, CE ;
Hospenthal, DR .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :776-782
[8]   Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection [J].
Engemann, JJ ;
Carmeli, Y ;
Cosgrove, SE ;
Fowler, VG ;
Bronstein, MZ ;
Trivette, SL ;
Briggs, JP ;
Sexton, DJ ;
Kaye, KS .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :592-598
[9]   Prevention and control of methicillin-resistant Staphylococcus aureus infections [J].
Farr, BM .
CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (04) :317-322
[10]   Performance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistance [J].
Kluytmans, J ;
Van Griethuysen, A ;
Willemse, P ;
Van Keulen, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) :2480-2482